A major breakthrough in cancer research is occurring with the use of nanobodies to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently inactivated in several types of tumors, causing https://bookmarkwuzz.com/story21953616/vhh-fragments-reactivate-p53-new-promising-hope-for-tumor-management